224 related articles for article (PubMed ID: 35747907)
1. Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme.
Clark GR; Fraser CG; Strachan JA; Steele RJ
J Med Screen; 2022 Dec; 29(4):249-254. PubMed ID: 35747907
[TBL] [Abstract][Full Text] [Related]
2. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
Digby J; Fraser CG; Carey FA; Diament RH; Balsitis M; Steele RJ
J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
[TBL] [Abstract][Full Text] [Related]
3. Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality.
Clark GR; Godfrey T; Purdie C; Strachan J; Carey FA; Fraser CG; Steele RJ
J Med Screen; 2024 Mar; 31(1):21-27. PubMed ID: 37469171
[TBL] [Abstract][Full Text] [Related]
4. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.
Senore C; Zappa M; Campari C; Crotta S; Armaroli P; Arrigoni A; Cassoni P; Colla R; Fracchia M; Gili F; Grazzini G; Lolli R; Menozzi P; Orione L; Polizzi S; Rapi S; Riggi E; Rubeca T; Sassatelli R; Visioli C; Segnan N
Gut; 2020 Mar; 69(3):523-530. PubMed ID: 31455608
[TBL] [Abstract][Full Text] [Related]
5. Impact of time between faecal immunochemical tests in colorectal cancer screening on screening results: A natural experiment.
Ribe SG; Botteri E; Løberg M; Randel KR; Kalager M; Nilsen JA; Gulichsen EH; Holme Ø
Int J Cancer; 2023 Apr; 152(7):1414-1424. PubMed ID: 36346118
[TBL] [Abstract][Full Text] [Related]
6. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
[TBL] [Abstract][Full Text] [Related]
7. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
[TBL] [Abstract][Full Text] [Related]
8. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
[TBL] [Abstract][Full Text] [Related]
9. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
[TBL] [Abstract][Full Text] [Related]
10. One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain).
Tourne-Garcia C; Perez-Riquelme F; Monteagudo-Piqueras O; Fraser CG; Yepes-Garcia P
J Med Screen; 2022 Dec; 29(4):231-240. PubMed ID: 35578555
[TBL] [Abstract][Full Text] [Related]
11. Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model.
Meester RGS; van de Schootbrugge-Vandermeer HJ; Breekveldt ECH; de Jonge L; Toes-Zoutendijk E; Kooyker A; Nieboer D; Ramakers CR; Spaander MCW; van Vuuren AJ; Kuipers EJ; van Kemenade FJ; Nagtegaal ID; Dekker E; van Leerdam ME; Lansdorp-Vogelaar I;
Gut; 2023 Jan; 72(1):101-108. PubMed ID: 35537811
[TBL] [Abstract][Full Text] [Related]
12. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
[TBL] [Abstract][Full Text] [Related]
13. Faecal haemoglobin concentration in adenoma, before and after polypectomy, approaches the ideal tumour marker.
Mowat C; Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJ; Strachan JA; Humphries A; Fraser CG
Ann Clin Biochem; 2022 Jul; 59(4):272-276. PubMed ID: 35235491
[TBL] [Abstract][Full Text] [Related]
14. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.
de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962
[TBL] [Abstract][Full Text] [Related]
15. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer in a second round after a negative faecal immunochemical test.
Bujanda L; Sarasqueta C; Castells A; Pellisé M; Cubiella J; Gil I; Cosme A; Arana-Arri E; Mar I; Idigoras I; Portillo I;
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):813-8. PubMed ID: 25856688
[TBL] [Abstract][Full Text] [Related]
17. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
[TBL] [Abstract][Full Text] [Related]
18. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.
Digby J; Fraser CG; Carey FA; Lang J; Stanners G; Steele RJ
J Med Screen; 2016 Sep; 23(3):130-4. PubMed ID: 26589788
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended?
Haug U; Grobbee EJ; Lansdorp-Vogelaar I; Spaander MCW; Kuipers EJ
Gut; 2017 Jul; 66(7):1262-1267. PubMed ID: 27006184
[TBL] [Abstract][Full Text] [Related]
20. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]